Expand RADX Menu
RADX MENU

RADX Latest Press Releases

-- January 28, 2026 --

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates Globe Newswire 7:00 AM

-- January 21, 2026 --

Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream Globe Newswire 7:00 AM

-- January 20, 2026 --

Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream Globe Newswire 7:00 AM

-- January 12, 2026 --

RAD Increases Ownership in Radiopharm Ventures to 87.5% Globe Newswire 7:00 AM

-- December 15, 2025 --

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases Globe Newswire 7:00 AM

-- November 18, 2025 --

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer Globe Newswire 8:30 AM

-- November 17, 2025 --

Radiopharm Theranostics Announces 50% Enrollment in Phase 2b Clinical Trial of RAD101 Imaging in Brain Metastases Globe Newswire 8:00 AM

-- November 12, 2025 --

Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204 Globe Newswire 8:30 AM

-- November 5, 2025 --

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing Globe Newswire 8:35 AM

-- October 31, 2025 --

CORRECTION -- International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 04, 2025 Globe Newswire 8:35 AM

-- October 30, 2025 --

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 04, 2025 Globe Newswire 8:56 AM

-- October 20, 2025 --

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs Globe Newswire 8:00 AM
Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan Globe Newswire 7:30 AM

-- October 1, 2025 --

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 'HEAT' Dose Escalation Clinical Trial Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes